Breakthrough BASHIR Endovascular Catheter approved by FDA for treatment of acute pulmonary embolism
The BASHIR Endovascular Catheter, invented at the Lewis Katz School of Medicine at Temple University and developed by Thrombolex, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of acute pulmonary embolism. The approval is based on data from the RESCUE study, a U.S. National Institutes of Health-sponsored multicentre clinical […]